Genprex Inc
For the period ended Dec 31, 2024. Filed Apr 1, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 1, 2025
GNPX$2.06-0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
| Year Ended | ||
|---|---|---|
| December 31, | ||
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $1,601,660 | $6,737,629 |
| Prepaid expenses and other | 475,807 | 794,138 |
| Total current assets | 2,077,467 | 7,531,767 |
| Property and equipment, net | — | 7,859 |
| Other assets: | ||
| Security deposits | — | 10,000 |
| Research and development supplies | 2,046,858 | 2,347,488 |
| Intellectual property, net | — | 773,478 |
| Total other assets | 2,046,858 | 3,130,966 |
| Total assets | $4,124,325 | $10,670,592 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $1,074,295 | $1,397,610 |
| Other current liabilities | 1,429,875 | 1,856,598 |
| Total current liabilities | 2,504,170 | 3,254,208 |
| Commitments and contingencies (Note 7) | ||
| Stockholders' equity: | ||
| Preferred stock $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding, respectively | — | — |
| Common stock $0.001 par value: 200,000,000 shares authorized; 10,860,655 and 1,485,902 shares issued and outstanding, respectively | 10,861 | 1,486 |
| Additional paid-in capital | 156,408,737 | 141,103,178 |
| Accumulated deficit | (154,799,443) | (133,688,280) |
| Total stockholders' equity | 1,620,155 | 7,416,384 |
| Total liabilities and stockholders' equity | $4,124,325 | $10,670,592 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.